HEM파마

376270KOSDAQ자연과학 및 공학 연구개발업

50.2 / 100

Reference Date: 2026-06-10

Financial Score14.0 / 40

News Sentiment20.2 / 25

Momentum4.0 / 20

Disclosure12.0 / 15

AI Analysis: the high debt ratio poses financial risk, Operating Profit is on a declining trend. Plunged 30.1% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

HEM Pharma is a global microbiome specialist company offering personalized healthcare services and LBP (Live Biotherapeutic Products) discovery platforms. Utilizing its proprietary PMAS technology, the company simulates microbiome environments to provide customized solutions and collaborates with global pharmaceutical firms and Amway, expanding into markets such as Japan and Vietnam.

Number of Employees

101people

Average Salary

55.3M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 62.704.0Point

PBR

—Industry Average 3.243.5Point

ROE

-151.43Industry Average -32.093.5Point

4.7x industry avg (excellent)

Debt Ratio

117.61Industry Average 7.310.0Point

16.1x industry avg (risky)

Trend 2023~20253.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲84.0% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼34.1% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -82.9% (declining, 3yr)

Detailed News Sentiment

11 totalPositive 10Neutral 1Negative 0Average Sentiment Score 80.9

Positive
신약 넘어 ‘맞춤형 장 건강’으로…K-마이크로바이옴, 웰니스 시장서.....
HEM파마 관련 마이크로바이옴 맞춤형 웰니스 서비스 진출로 새로운 시장 기회 확대.
Positive
아우토크립트·HEM파마, 피지컬AI 플랫폼 '바이그널' 보안 협력
HEM파마와 아우토크립트의 MOU 체결로 피지컬 AI 플랫폼 보안 강화, 기술 협력 기대감 상승.
Positive
HEM파마, 아우토크립트와 손잡고 헬스케어 플랫폼 보안 강화
HEM파마와 아우토크립트의 협력으로 헬스케어 플랫폼 보안 강화, 기업의 기술적 신뢰성 향상 기대.

Detailed Momentum

52-week position3.0Point

52w lower range (32%)

Current 43,000Won52-week high 94,00052-week low 18,180

1-month return0.0Point

1m -30.08% (strong drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

2 totalPositive 1Neutral 1Negative 0

Neutral기업설명회(IR)개최2026-05-22
Positive단일판매ㆍ공급계약체결2026-05-14